Approval · Notice of Compliance 21092 · 2018
ROCURONIUM BROMIDE INJECTION: Notice of Compliance 21092
Issued July 16, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21092
- Date
- July 16, 2018
- Company
- Mda Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Canadian reference product
- ZEMURON (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROCURONIUM BROMIDE INJECTION | Not yet assigned | — |
Medicinal ingredients
- ROCURONIUM BROMIDE 10 MG per ML